[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Kaken Pharmaceutical Co. Ltd.
Kaken Pharmaceutical partners with Astria Therapeutics to develop and sell Navenibart for HAE in Japan. Alumis and Kaken Pharmaceutical announce collaboration and licensing agreement for ESK-001 in Dermatology in Japan, driving social engagement and mentions on X (formerly Twitter).
About Kaken Pharmaceutical Co. Ltd.
Kaken Pharmaceutical Co. Ltd. is a pharmaceutical company.
Price: $ #
Price 24-Hour Time-Series Raw Data
The price action is likely influenced by the recent licensing agreements and collaborations, particularly the partnership with Astria Therapeutics, which could be driving positive sentiment and potentially influencing the price.
1-Year High: $XXXXX on 2025-03-12
1-Year Low: $XXXXX on 2025-10-01
AltRank: undefined #
AltRank 24-Hour Time-Series Raw Data
Kaken Pharmaceutical Co. Ltd. is currently AltRank #undefined based on combined combined social and market metrics
Daily Average: XXXXX
1-Year High: XXXXX on 2025-02-27
1-Year Low: XXX on 2025-02-25
Galaxy Score: XX #
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2024-12-19
1-Year Low: XX on 2025-02-11
Engagements: XX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1 Week: XXX -XX%
1 Month: XXXXX +653%
6 Months: XXXXXX +0.60%
1 Year: XXXXXX +1,475%
1-Year High: XXXXX on 2025-04-08
1-Year Low: X on 2025-02-08
| Social Network | X | YouTube |
|---|---|---|
| Engagements | XX | X |
Mentions: X #
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
6 Months: XX -XX%
1 Year: XX +830%
1-Year High: XX on 2025-03-25
1-Year Low: X on 2024-11-27
| Social Network | X | YouTube |
|---|---|---|
| Mentions | X | X |
Creators: X #
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning Kaken Pharmaceutical Co. Ltd. in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: X
6 Months: XX -XX%
1 Year: XX +700%
1-Year High: XX on 2025-03-25
1-Year Low: X on 2024-11-27
Sentiment: % #
Sentiment 24-Hour Time-Series Raw Data
Current Value: %
Daily Average: XXX%
1 Week: XXX% no change
1 Month: XXX% no change
6 Months: XXX% no change
1 Year: XXX% no change
1-Year High: XXX% on 2024-11-28
1-Year Low: XXX% on 2024-11-28
Market Cap: $undefined #
Market Cap 24-Hour Time-Series Raw Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXXX on 2025-03-12
1-Year Low: $XXXXXXXXXXXXXXX on 2024-10-17
Top assets mentioned In the posts about Kaken Pharmaceutical Co. Ltd. in the last XX hours
Top topics mentioned In the posts about Kaken Pharmaceutical Co. Ltd. in the last XX hours
$atxs, japan, hae, monaco, sec, joint ventures, life of, superior, $40m, $xbi
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
": @AstriaTx licensed its HAE treatment Navenibart to Kaken Pharmaceutical for the Japanese market. It is a kallikrein inhibitor that is in phase X and is dosed up to every six months. $ATXS Full video:"
X Link @BiotechTV 2025-08-07T19:25Z 9438 followers, 1828 engagements
"$ATXS Astria Therapeutics partners with Kaken Pharmaceutical to develop and sell Navenibart for HAE in Japan. More Info: $XBI $IBB $XPH $PPH"
X Link @OzmosiHealth 2025-08-06T12:34Z 2774 followers, XXX engagements
"$ATXS Joint Ventures: On August X 2025 Astria Therapeutics Inc. signed a license agreement with Kaken Pharmaceutical granting Kaken rights to develop and commercialize navenibart in Japan for $XX million upfront plus potential additional payments and royalties. The agreement also includes collaboration on clinical trials and regulatory submissions for navenibart"
X Link @USCorpFilings 2025-08-06T12:30Z 6117 followers, XXX engagements
"$ATXS Astria Therapeutics Enters into Licensing Agreement with Kaken Pharmaceutical to Develop and Commerc. - ATXS BioPharmCatalyst"
X Link @monaco_biotech 2025-08-06T12:09Z 5761 followers, XXX engagements